Authors/Disclosures
|
Allison Brashear, MD, MBA, FAAN
(Univeristy of Buffalo)
|
Dr. Brashear has received personal compensation for serving as an employee of McKnight Brain Res Found. Dr. Brashear has received personal compensation for serving as an employee of American Board of Psychiatry and Neurology. Dr. Brashear has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for ABPN. Dr. Brashear has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for McKnight Brain Research Foundation i. Dr. Brashear has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Care Directions- start up . Dr. Brashear has stock in Caredirections . The institution of Dr. Brashear has received research support from NINDS. Dr. Brashear has received publishing royalties from a publication relating to health care. Dr. Brashear has received personal compensation in the range of $500-$4,999 for serving as a Special government employee and study section reviewer with NIH. Dr. Brashear has received personal compensation in the range of $0-$499 for serving as a Adminstrative board -travel reimbursement with AAMC. |
|
|
No disclosure on file |
|
Amie L. Hiller, MD
|
The institution of Dr. Hiller has received research support from Admas Pharmaceuticals. |
|
William B. Dobyns, MD
|
No disclosure on file |
|
Joseph F. Quinn, MD, FAAN
(OHSU Neurology)
|
Dr. Quinn has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Retrophin. Dr. Quinn has received personal compensation in the range of $500-$4,999 for serving as a DSMB with Alzheimer's Disease Cooperative Study. Dr. Quinn has received personal compensation in the range of $500-$4,999 for serving as a DSMB with Alzheimer's Therapeutic Research Institute. Dr. Quinn has a non-compensated relationship as a consultant with Cognition Therapeutics that is relevant to AAN interests or activities. |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Peter T. Schmidt, PhD
|
No disclosure on file |
|
|
No disclosure on file |
|
Deborah Raymond
(Beth Isreal Medical Center)
|
The institution of Ms. Raymond has received research support from NIH. |
|
Susan B. Bressman, MD, FAAN
(Mount Sinai Health System)
|
The institution of Dr. Bressman has received research support from Michael J Fox Foundation . The institution of Dr. Bressman has received research support from NIH . |
|
Laurie J. Ozelius, PhD
|
The institution of Dr. Ozelius has received research support from NIH. Dr. Ozelius has received intellectual property interests from a discovery or technology relating to health care. |